Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LENALIDOMIDE Cause Product administration interrupted? 146 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 146 reports of Product administration interrupted have been filed in association with LENALIDOMIDE (LENALIDOMIDE). This represents 0.0% of all adverse event reports for LENALIDOMIDE.

146
Reports of Product administration interrupted with LENALIDOMIDE
0.0%
of all LENALIDOMIDE reports
0
Deaths
8
Hospitalizations

How Dangerous Is Product administration interrupted From LENALIDOMIDE?

Of the 146 reports, 8 (5.5%) required hospitalization.

Is Product administration interrupted Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LENALIDOMIDE. However, 146 reports have been filed with the FAERS database.

What Other Side Effects Does LENALIDOMIDE Cause?

Diarrhoea (27,576) Fatigue (22,956) Death (19,213) Off label use (17,017) Rash (15,794) Pneumonia (14,807) Plasma cell myeloma (14,191) Neuropathy peripheral (10,215) White blood cell count decreased (9,996) Constipation (9,635)

What Other Drugs Cause Product administration interrupted?

CALCIUM OXYBATE\MAGNESIUM OXYBATE\POTASSIUM OXYBATE\SODIUM OXYBATE (1,446) SODIUM OXYBATE (1,272) CANNABIDIOL (511) ISOTRETINOIN (503) APREMILAST (314) TREPROSTINIL (295) EPOPROSTENOL (205) ETANERCEPT (142) INTERFERON BETA-1A (115) ADALIMUMAB (86)

Which LENALIDOMIDE Alternatives Have Lower Product administration interrupted Risk?

LENALIDOMIDE vs LENIOLISIB LENALIDOMIDE vs LENOGRASTIM LENALIDOMIDE vs LENVATINIB LENALIDOMIDE vs LEPONEX LENALIDOMIDE vs LERCANIDIPINE

Related Pages

LENALIDOMIDE Full Profile All Product administration interrupted Reports All Drugs Causing Product administration interrupted LENALIDOMIDE Demographics